MedPath

Analysis of glioblastoma-metabolism by MRI-Spectroscopy

Conditions
C71.9
Brain, unspecified
Registration Number
DRKS00014760
Lead Sponsor
Abt. Neurochirurgie UKSH Kiel
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
44
Inclusion Criteria

Intracranial tumors

Exclusion Criteria

in need of protection (children)

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Minimum 10 patients should be examinated with MRS (magnetic resonance spectroscopy). The results of edge and central regions of the tumor will be compared.
Secondary Outcome Measures
NameTimeMethod
The data-research is to be continued for about three years.
© Copyright 2025. All Rights Reserved by MedPath